1 results match your criteria: "Director of the Thomas Jefferson University and Jefferson Sleep Disorders Center[Affiliation]"
J Am Assoc Nurse Pract
October 2024
Director of the Thomas Jefferson University and Jefferson Sleep Disorders Center, Philadelphia, Pennsylvania; Biogen, Harmony, and Axsome.
Background: Obstructive sleep apnea (OSA) affects patient health and public welfare. Positive airway pressure (PAP) therapy is the preferred treatment of OSA, but therapy adherence rates remain suboptimal. Current literature demonstrates telemonitoring interventions to support improved PAP therapy adherence.
View Article and Find Full Text PDF